Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06361095 · ClinicalTrials.gov registry record · Early Phase 1
Confirmatory Efficacy Trial of Attention Bias Modification for Depression
A Early Phase 1 study of Depression, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT06361095 is a Early Phase 1 study of Depression that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 600 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06361095, a Early Phase 1 study of Depression, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the efficacy of two related, but different ABM (Attention Biased Modification) treatments for depression in adults with elevated symptoms of depression. The main aims are: * Aim 1:examine whether gamified ABM leads to greater change in the primary and secondary outcomes than sham ABM * Aim 1: establish that gamified ABM is at least as effective as traditional ABM. * Aim 2: identify moderators of ABM efficacy and mechanisms responsible for its efficacy. * Aim 3: Identify the durability of ABM on depression symptoms during short-term follow-up Participants will complete self-report questionnaires, complete eye-tracking tasks, and be clinically assessed through interviews by clinician researchers. If there is a comparison group: Researchers will compare sham, traditional, and gamified treatment groups to see if they moderate symptoms of depression.
Conditions Studied
Interventions
- BEHAVIORAL Traditional Attention Bias Modification
- BEHAVIORAL Gamified Attention Bias Modification
- BEHAVIORAL Sham Attention Bias Modification
Study Locations (1)
Texas
- Institute for Mental Health Research - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2028-05-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06361095
The ClinicalTrials.gov registry entry for NCT06361095 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 679 other Depression trials with a reported enrollment target (24% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Traditional Attention Bias Modification is the first listed.
NCT06361095 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06361095 about?
NCT06361095 is a clinical study titled "Confirmatory Efficacy Trial of Attention Bias Modification for Depression". The goal of this clinical trial is to compare the efficacy of two related, but different ABM (Attention Biased Modification) treatments for depression in adults with elevated symptoms of depression. The main aims are: * Aim 1:examine whether gamified ABM leads to greater change in the primary and s...
What is the current status of trial NCT06361095?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 600 participants. The study started on 2024-05-01. Estimated completion is 2028-05-01.
What conditions does trial NCT06361095 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT06361095?
The interventions under investigation include: Traditional Attention Bias Modification (BEHAVIORAL), Gamified Attention Bias Modification (BEHAVIORAL), Sham Attention Bias Modification (BEHAVIORAL).
Who is sponsoring clinical trial NCT06361095?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06361095 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
-
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
RECRUITING · Early Phase 1
-
Probiotic Administration for Adolescent Depression
RECRUITING · Early Phase 1
-
Mood Effects of Serotonin Agonists: Depression
RECRUITING · Early Phase 1
-
Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)
ACTIVE NOT RECRUITING · Early Phase 1
-
Testing a Transdiagnostic TMS Treatment Target
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.